Literature DB >> 28867168

The Unfolded Protein Response in Immunogenic Cell Death and Cancer Immunotherapy.

Nicole Rufo1, Abhishek D Garg1, Patrizia Agostinis2.   

Abstract

The unfolded protein response (UPR) is a conserved pathway that is stimulated when endoplasmic reticulum (ER) proteostasis is disturbed or lost. Accumulating evidence indicates that chronic activation of the UPR supports the main hallmarks of cancer by favoring cancer cell-autonomous and nonautonomous processes, which ultimately foster the immunosuppressive and protumorigenic microenvironment. However, certain forms of therapy-induced ER stress can elicit immunogenic cancer cell death (ICD), which enables the release of key immunostimulatory or danger signals, eventually driving efficient antitumor immunity. In this review, after a brief discussion of the interplay between ER stress and protumorigenic inflammation, we review the relevance of therapy-mediated ER stress pathways in evoking ICD and how they could be used to optimize current immunotherapy approaches against cancer.
Copyright © 2017 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  endoplasmic reticulum stress; immunogenic cell death; immunotherapy

Mesh:

Year:  2017        PMID: 28867168     DOI: 10.1016/j.trecan.2017.07.002

Source DB:  PubMed          Journal:  Trends Cancer        ISSN: 2405-8025


  50 in total

Review 1.  Nanomedicine and macroscale materials in immuno-oncology.

Authors:  Qingxue Sun; Matthias Barz; Bruno G De Geest; Mustafa Diken; Wim E Hennink; Fabian Kiessling; Twan Lammers; Yang Shi
Journal:  Chem Soc Rev       Date:  2019-01-02       Impact factor: 54.564

2.  Photodynamic therapy with redaporfin targets the endoplasmic reticulum and Golgi apparatus.

Authors:  Lígia C Gomes-da-Silva; Liwei Zhao; Lucillia Bezu; Heng Zhou; Allan Sauvat; Peng Liu; Sylvère Durand; Marion Leduc; Sylvie Souquere; Friedemann Loos; Laura Mondragón; Baldur Sveinbjørnsson; Øystein Rekdal; Gaelle Boncompain; Franck Perez; Luis G Arnaut; Oliver Kepp; Guido Kroemer
Journal:  EMBO J       Date:  2018-05-28       Impact factor: 11.598

Review 3.  Regulation of autophagy by canonical and non-canonical ER stress responses.

Authors:  Monika Bhardwaj; Nektaria Maria Leli; Constantinos Koumenis; Ravi K Amaravadi
Journal:  Semin Cancer Biol       Date:  2019-12-12       Impact factor: 15.707

Review 4.  Facts and Hopes in Multiple Myeloma Immunotherapy.

Authors:  Adam S Sperling; Kenneth C Anderson
Journal:  Clin Cancer Res       Date:  2021-03-26       Impact factor: 12.531

5.  Expression profiles of Natural Killer Group 2D Ligands (NGK2DLs) in colorectal carcinoma and changes in response to chemotherapeutic agents.

Authors:  Burak Kucuk; Esra Yilmaz; Ercan Cacan
Journal:  Mol Biol Rep       Date:  2021-05-19       Impact factor: 2.316

Review 6.  Dendritic cell vaccine therapy for colorectal cancer.

Authors:  Amanda L Wooster; Lydia H Girgis; Hayley Brazeale; Trevor S Anderson; Laurence M Wood; Devin B Lowe
Journal:  Pharmacol Res       Date:  2020-12-28       Impact factor: 7.658

7.  4-(N)-Docosahexaenoyl 2', 2'-difluorodeoxycytidine induces immunogenic cell death in colon and pancreatic carcinoma models as a single agent.

Authors:  Stephanie Hufnagel; Haiyue Xu; Michael F Colemam; Solange A Valdes; Kristyn A Liu; Stephen D Hursting; Zhengrong Cui
Journal:  Cancer Chemother Pharmacol       Date:  2021-10-26       Impact factor: 3.333

Review 8.  Endoplasmic reticulum stress signals in the tumour and its microenvironment.

Authors:  Xi Chen; Juan R Cubillos-Ruiz
Journal:  Nat Rev Cancer       Date:  2020-11-19       Impact factor: 60.716

9.  A small-molecule activator of the unfolded protein response eradicates human breast tumors in mice.

Authors:  Matthew W Boudreau; Darjan Duraki; Lawrence Wang; Chengjian Mao; Ji Eun Kim; Madeline A Henn; Bingtao Tang; Sean W Fanning; Jeffrey Kiefer; Theodore M Tarasow; Elizabeth M Bruckheimer; Ramon Moreno; Spyro Mousses; Geoffrey L Greene; Edward J Roy; Ben Ho Park; Timothy M Fan; Erik R Nelson; Paul J Hergenrother; David J Shapiro
Journal:  Sci Transl Med       Date:  2021-07-21       Impact factor: 17.956

10.  Bullatacin triggers immunogenic cell death of colon cancer cells by activating endoplasmic reticulum chaperones.

Authors:  Fangtian Fan; Peiliang Shen; Yue Ma; Wangbo Ma; Hongyan Wu; Hao Liu; Qing An
Journal:  J Inflamm (Lond)       Date:  2021-06-10       Impact factor: 4.981

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.